Alyeska Investment Group’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.33M Buy
+102,518
New +$1.33M ﹤0.01% 489
2017
Q1
Sell
-116,359
Closed -$1.71M 448
2016
Q4
$1.71M Sell
116,359
-34,938
-23% -$513K 0.01% 389
2016
Q3
$2.62M Buy
151,297
+4,122
+3% +$71.3K 0.02% 360
2016
Q2
$4.63M Sell
147,175
-2,698
-2% -$84.8K 0.04% 308
2016
Q1
$3.98M Buy
149,873
+6,950
+5% +$184K 0.04% 288
2015
Q4
$6.28M Buy
142,923
+63,584
+80% +$2.8M 0.07% 246
2015
Q3
$3.35M Buy
+79,339
New +$3.35M 0.04% 289